Ocugen

1 follower

‌

Ocugen Inc. (NASDAQ: OCGN) is a biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to fight COVID-19.

Industries

Employees

51-200

Links


Org chart

Shankar Musunuri
Chairman, CEO & Co-founder
Collapse
Arun Upadhyay
Chief Scientific Officer, Head of Research & Development & Medical
Mike Shine
SVP, Commercial
Jyothy Pillai
Head, Regulatory & Quality
Tiffany J. Hamilton
Avp, Head Of Corporate Communications
Michael Breininger
Corporate Controller
Kristen Craft
Head Of Human Resources
Ramesh Ramachandran
Chief Accounting Officer & Principal Financial Officer

Board & advisors

Junge Zhang
Director
David Boyer
Scientific Advisor
Carl D. Regillo
Scientific Advisor
Mark Pennesi
Scientific Advisor
Geeta Lalwani
Scientific Advisor
Satish Chandran
Scientific Advisor
Catherine Pachuk
Scientific Advisor
Harvey Rubin
Scientific Advisor
David Fajgenbaum
Scientific Advisor
Susan Weiss
Scientific Advisor
Bruce D. Forrest
Scientific Advisor
Pat Toomey
Advisor